000			01459 a2200409 4500
005			20250515050727.0
264		0	_c20070501
008			200705s 0 0 eng d
022			_a0028-3908
024	7		_a10.1016/j.neuropharm.2006.09.024 _2doi
040			_aNLM _beng _cNLM
100	1		_aEaston, Neil
245	0	0	_aAtomoxetine produces changes in cortico-basal thalamic loop circuits: assessed by phMRI BOLD contrast. _h[electronic resource]
260			_bNeuropharmacology _cMar 2007
300			_a812-26 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdrenergic Uptake Inhibitors _xpharmacology
650	0	4	_aAnimals
650	0	4	_aAtomoxetine Hydrochloride
650	0	4	_aBlood Pressure _xdrug effects
650	0	4	_aBrain Mapping
650	0	4	_aCerebral Cortex _xdrug effects
650	0	4	_aCerebrovascular Circulation _xdrug effects
650	0	4	_aMagnetic Resonance Imaging _xmethods
650	0	4	_aMale
650	0	4	_aNeural Pathways _xdrug effects
650	0	4	_aPropylamines _xpharmacology
650	0	4	_aRats
650	0	4	_aRats, Sprague-Dawley
650	0	4	_aThalamus _xdrug effects
650	0	4	_aTime Factors
700	1		_aMarshall, Fiona
700	1		_aFone, Kevin
700	1		_aMarsden, Charles
773	0		_tNeuropharmacology _gvol. 52 _gno. 3 _gp. 812-26
856	4	0	_uhttps://doi.org/10.1016/j.neuropharm.2006.09.024 _zAvailable from publisher's website
999			_c16710646 _d16710646